USTR is announcing that it invites any trading partner appearing on the Special 301 Priority Watch List or Watch List to work with the United States to develop a mutually agreed action plan designed to lead to that trading partner’s removal from the relevant list. Agreement on such a plan will not by itself change a trading partner’s status in the Special 301 Report.
This year’s list includes Canada along with several Western European countries (Finland, Italy, Greece, Spain, and Norway) and dozens of other countries around the world. The total population of the 40 countries on the list exceeds 4.3 billion. Many of these are poor countries with per person GDPs of a few thousand dollars per year, yet the primary complaint tends to revolve around patent protection and approval for pharmaceutical drugs.